| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5592 | Z1913661252 | Novel riboswitch activator, binding ZTP riboswitches, and activating transcription more strongly than ZMP in vitro |
|
| DCC5593 | Z4446724338 | Novel potent dual σ1/2 ligand (σ1 K i =5nM, σ2 K i =3nM), showing anti-allodynic in a model of neuropathic pain |
|
| DCC5594 | Z56965384 | Novel USP10 inhibitor |
|
| DCC5595 | Zarilamide | Inhibitor of the nuclear division in germinating zoospore cysts of Phytophthora capsici via destruction of the microtubule cytoskeleton, and a consequent inhibition of mitosis |
|
| DCC5596 | Zatosetron | Serotonin 5-HT3 receptor antagonist |
|
| DCC5597 | Zbh-1205 | Novel camptothecin derivative, revealing potent antitumor activities mainly through cell apoptosis pathway, being more effective than CPT-11 and SN38 at inhibiting topoismerase-1 |
|
| DCC5598 | Zd1611 | Endothelin Receptor Antagonist |
|
| DCC5599 | Zd2138 | Potent, orally active inhibitor of 5-lipoxygenase (5-LO) |
|
| DCC5600 | Zd6126 | Vascular targeting agent (VTA) |
|
| DCC5601 | zd6169 | Potassium channel opener |
|
| DCC5602 | Zdhhc Substrate Peptide | ZDHHC (zinc finger Asp-His-His-Cys) substrate peptide, a 15-mer peptide sequence from KRas4a plus two tryptophan residues |
|
| DCC5603 | Zdlt-1 | Novel potent HDAC inhibitor with IC50 values for class I HDACs 1, 2, and 3 below 4 nM, and IC50 for HDAC6 at 6 nM. |
|
| DCC5604 | Z-don-val-pro-leu-ome | Site specific inhibitor of tissue transglutaminase |
|
| DCC5605 | Zdwx-25 | Novel daul inhibitor of GSK-3β (IC 50 = 71 nM) and DYRK1A (IC 50 = 103 nM) with good blood-brain barrier penetrability, inhibiting hyperphosphorylation of tau protein in okadaic acid (OKA)-induced SH-SY5Y cells |
|
| DCC5606 | Zfh7116 | Novel inhibitor of pro-HGF activation |
|
| DCC5607 | Zg-2033 | Novel Potent and Orally Bioavailable Hypoxia-Inducible Factor 2α (HIF-2α) Agonist |
|
| DCC5608 | Z-ggr-amc | Fluorogenic peptide substrate for a direct fluorometric assay of urokinase, tissue-type plasminogen activator, trypsin and thrombin |
|
| DCC5609 | Ziconotide | Atypical analgesic agent for the amelioration of severe and chronic pain |
|
| DCC5610 | Zilpaterol | Growth promotant, acting as a ß-AR (ß-Adrenergic) agonist |
|
| DCC5611 | Zinc00723145 | The first nonpeptidic inhibitor of ovarian cancer cells growth targeting human thymidylate synthase (hTS) |
|
| DCC5612 | Zinc01765622 | Novel antagonist for mLST8 |
|
| DCC5613 | Zinc03838680 | Potent VEGFR-2 inhibitor |
|
| DCC5614 | Zinc04085549 | Novel blocker of AKT1-FAK interaction, reducing the stimulation of FAK phosphorylation in response to extracellular pressure in human SW620 colon cancer cells without affecting basal FAK phosphorylation |
|
| DCC5615 | Zinc04177596 | Novel Nef Protein Inhibitor; Anti-HIV |
|
| DCC5616 | Zinc04502991 | Novel TNF-α inhibitor |
|
| DCC5617 | Zinc04515726 | Novel effective immune checkpoint inhibitor (ICI) against the suppression of T-cell activation, proliferation, and tumor cell eradication. |
|
| DCC5618 | Zinc04574788 | Novel potent small molecule lligand of miR-21, binding to the major groove of miR-21 hairpin conformation |
|
| DCC5619 | Zinc05848961 | Novel TNF-α inhibitor |
|
| DCC5620 | Zinc06472206 | Potent and selective agonist of peroxisome proliferator activated receptors-α (PPAR-α) |
|
| DCC5621 | Zinc08438472 | Potent and selective agonist of peroxisome proliferator activated receptors-α (PPAR-α) |
|
